[The effects of imatinib mesylate on immune globulin and T cell subset in patients with chronic myelocytic leukemia].

Gui, Rui-rui; Zhang, Yan-li; Fang, Bai-jun

Gui, Rui-rui; Zhang, Yan-li; Fang, Bai-jun.

Zhonghua Xue Ye Xue Za Zhi ; 33(3): 225-6, 2012 Mar.

Article in Zh | MEDLINE | ID: mdl-22781613

Subject(s)

Benzamides/therapeutic use; Immunoglobulins/metabolism; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology; Piperazines/therapeutic use; Pyrimidines/therapeutic use; T-Lymphocyte Subsets; Adult; Aged; Case-Control Studies; Female; Humans; Imatinib Mesylate; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Benzamides / Immunoglobulins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / T-Lymphocyte Subsets Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Xue Ye Xue Za Zhi Year: 2012 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links